Common reflux drug may speed up COVID-19 recovery

Famotidine 'accelerates resolution' of symptoms and is well-tolerated, say researchers in the journal Gut

Treatment with a common gastric reflux drug may speed up recovery in patients with mild to moderate COVID-19, a new trial suggests.

The prescription of high dose famotidine led to early resolution of symptoms and inflammation, shows the randomised placebo-controlled trial in the US.

The histamine 2 receptor antagonist improved resolution of 14 of 16 assessed symptoms, including loss of smell and taste, difficulty breathing and abdominal pain. 

It also led